ISMOTIC

LOE Approaching

isosorbide

NDAORALSOLUTION
Approved
Jan 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5

Clinical Trials (5)

NCT07121634N/AActive Not Recruiting

Cervical Ripening With Misoprostol vs Isosorbide Mononitrate ; A Parallel -Arm Randomized Controlled Trial

Started Jan 2024
NCT04051957Phase 2Terminated

Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury

Started Sep 2019
9 enrolled
Kidney InjuryProteinuriaHypertension
NCT03557580Phase 1Completed

A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects

Started Apr 2018
12 enrolled
Bioequivalence
NCT02101710Phase 1Completed

Pharmacokinetic Properties of Isosorbide-5-mononitrate Under Fasting and Fed Condition in Healthy Male Subjects

Started Jun 2011
60 enrolled
Healthy
NCT00871871Phase 1Completed

Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)

Started Mar 2009
64 enrolled
Hypertension